Found: 10
Select item for more details and to access through your institution.
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-α]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
- Published in:
- Molecules, 2018, v. 23, n. 1, p. 48, doi. 10.3390/molecules23010048
- By:
- Publication type:
- Article
A New Theobromine-Based EGFR WT and EGFR T790M Inhibitor and Apoptosis Inducer: Design, Semi-Synthesis, Docking, DFT, MD Simulations, and In Vitro Studies.
- Published in:
- Processes, 2022, v. 10, n. 11, p. 2290, doi. 10.3390/pr10112290
- By:
- Publication type:
- Article
Development of Novel Class of Phenylpyrazolo[3,4- d ]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 15026, doi. 10.3390/ijms241915026
- By:
- Publication type:
- Article
Design, synthesis, anticancer, and docking of some S‐ and/or N‐heterocyclic derivatives as VEGFR‐2 inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100237
- By:
- Publication type:
- Article
Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 3, p. 1, doi. 10.1002/ardp.202000237
- By:
- Publication type:
- Article
5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 9, p. 1, doi. 10.1002/ardp.202000079
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents.
- Published in:
- ISRN Organic Chemistry, 2013, p. 1, doi. 10.1155/2013/587054
- By:
- Publication type:
- Article
Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists.
- Published in:
- Molecular Diversity, 2021, v. 25, n. 1, p. 291, doi. 10.1007/s11030-020-10070-w
- By:
- Publication type:
- Article
Design, Synthesis, In Vitro, and In Silico Studies of New N 5 -Substituted-pyrazolo[3,4- d ]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1593, doi. 10.3390/ph16111593
- By:
- Publication type:
- Article
Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 226, doi. 10.3390/ph15020226
- By:
- Publication type:
- Article